This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yagel, S. K. Articles by Frosco, M. B. Search for Related Content PubMed PubMed Citation Articles by Yagel, S. K. Articles by Frosco, M. B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 12 1996, 2894-2897, Vol 40, No. 12
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia

SK Yagel, JF Barrett, DJ Amaratunga and MB Frosco
R. W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869, USA.

The in vivo efficacies of levofloxacin and ciprofloxacin in lethal, systemic Pseudomonas aeruginosa infections in mice were compared. MICs of levofloxacin and ciprofloxacin ranged from 0.5 to 2.0 micrograms/ml and from 0.12 to 1.0 microgram/ml respectively. Infecting doses ranged from 5.0 x 10(1) to 3.2 x 10(3) CFU per mouse, depending on the isolate. Test fluoroquinolones were administered orally at 1 h (single dose) or at 1 and 3 h (divided dose) postinfection, with 10 infected mice used for each of six concentrations of each fluoroquinolone tested (1 to 40 mg/kg of body weight) in each dosing regimen. Whether given in a single or a divided dose, the total daily dose was the same for each fluoroquinolone. For mice treated 1 h postinfection with levofloxacin and ciprofloxacin, the effective doses for 50% of the infected mice ranged from 2.09 to 13.80 mg/kg and from 2.34 to 11.22 mg/kg, respectively, and for those treated 1 and 3 h postinfection, the effective doses for 50% of the infected mice ranged from 3.71 to 16.98 mg/kg and from 2.95 to 13.18 mg/kg, respectively. Although the potency varied for both levofloxacin and ciprofloxacin among all strains of P. aeruginosa tested, there were small differences within the same strain for levofloxacin and ciprofloxacin when given in the same dosing regimen. Levofloxacin proved nearly as effective as ciprofloxacin against a systemic P. aeruginosa infection in mice.

This article has been cited by other articles:

• Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., Blasi, U. (2004). Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage. Antimicrob. Agents Chemother. 48: 3817-3822 [Abstract] [Full Text]  
• Segatore, B., Setacci, D., Perilli, M., Franceschini, N., De Santis, A., Marchetti, F., Amicosante, G. (1999). Italian Survey on Comparative Levofloxacin Susceptibility in 334 Clinical Isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 428-431 [Abstract] [Full Text]